RRH and atherosclerosis: At the same time, KEGG enrichment analysis revealed the potential signaling pathways of RRH in the treatment of chronic hepatitis, including Hepatitis B (hsa05161), Hepatitis C (hsa05160), Chemical carcinogenesis-receptor activation (hsa05207), Lipid and atherosclerosis signaling pathway (hsa05417).